<DOC>
	<DOC>NCT01244464</DOC>
	<brief_summary>This study is designed to obtain post-marketing safety data on IMOVAX Polio™ vaccine in China. Primary Objective: To describe the safety profile after each dose of IMOVAX Polio™ administered at 2, 3, and 4 months of age in population aged over 2 months old living in the study city China.</brief_summary>
	<brief_title>A Study of the Safety of IMOVAX Polio™ in China</brief_title>
	<detailed_description>Study participants will receive a single dose of IMOVAX Polio™ vaccine at 2, 3, and 4 months of age, respectively. Each participant will make a total of 7 visits. Safety will be monitored at each visit and up to 30 days after each vaccination.</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<criteria>Inclusion Criteria : Subject is more than 2 months (6089 days) old when receiving the first dose of polio vaccine. Subject's parents/legal representative showed willingness to complete the 3 primary doses fully using IMOVAX Polio™ according to the schedule: one injection at 2, 3, 4 months old, respectively. Informed consent form obtained from the subject's parent/legal representative. Subject plan to live in the selected study sites for at least three months after inclusion. Exclusion Criteria : Subject with a history of serious illness (e.g., hypersensitivity, seizure, convulsion, encephalopathy diseases) Known or suspected impairment of immunologic function Acute medical illness with or without fever within the last 72 hours Subject plan to leave the study sites for at least three months after inclusion Administration of immune globulin or other blood products within the last three months Participation in another clinical trial at the same time Contraindication to vaccination according to IMOVAX Polio™ leaflet.</criteria>
	<gender>All</gender>
	<minimum_age>60 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Poliomyelitis</keyword>
	<keyword>IMOVAX POLIO™</keyword>
	<keyword>Polio</keyword>
</DOC>